Management of refractory myeloma: a review.

One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation

1977 • 953 citations

Effective Treatment of Advanced Multiple Myeloma Refractory to Alkylating Agents

1984 • 667 citations

HIGH-DOSE INTRAVENOUS MELPHALAN FOR PLASMA-CELL LEUKAEMIA AND MYELOMA

1983 • 515 citations

High-dose melphalan with autologous bone marrow transplantation for multiple myeloma

1986 • 336 citations

High-dose chemoradiotherapy and autologous bone marrow transplantation for resistant multiple myeloma

1987 • 270 citations

Multiple myeloma treated with high dose intravenous melphalan

1987 • 251 citations

High-Dose Glucocorticoid Treatment of Resistant Myeloma

1986 • 251 citations

Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol

1977 • 222 citations

Combination chemotherapy for multiple myeloma

1972 • 213 citations

Antigens on human plasma cells identified by monoclonal antibodies.

1983 • 207 citations

A randomized trial of maintenance versus no maintenance melphalan and prednisone in responding multiple myeloma patients

1988 • 163 citations

The role of radiation therapy in the management of plasma cell tumors

1980 • 148 citations

Treatment of multiple myeloma with recombinant alpha-interferon

1986 • 129 citations

Oral melphalan kinetics

1979 • 110 citations

Phase II study of recombinant alpha-2 interferon in resistant multiple myeloma.

1985 • 108 citations

Reversal of drug‐resistance in multiple myeloma with verapamil

1988 • 102 citations

Unmaintained remissions in multiple myeloma

1978 • 96 citations

Chemotherapy for multiple myeloma

1984 • 90 citations

Prednisone pulse therapy for refractory myeloma

1983 • 83 citations

Plasma cell myeloma: response of melphalan-resistant patients to high-dose intermittent cyclophosphamide.

1972 • 82 citations

Human myeloma in vitro colony growth: interrelationships between drug sensitivity, cell kinetics, and patient survival duration

1983 • 79 citations

Elimination of clonogenic Burkitt's lymphoma cells from human bone marrow using 4-hydroperoxycyclophosphamide in combination with monoclonal antibodies and complement

1985 • 76 citations

The Current Status and Future Prospects of Treatment for Multiple Myeloma

1982 • 68 citations

Identical Twin Marrow Transplantation in Multiple Myeloma

1982 • 66 citations

Bone marrow transplantation in multiple myeloma: report from the European Cooperative Group for Bone Marrow Transplantation

1987 • 61 citations

Correlation between in vitro and in vivo sensitivity to human leucocyte interferon in patients with multiple myeloma

1985 • 61 citations

High-dose cyclophosphamide. An effective treatment for advanced refractory multiple myeloma

1984 • 53 citations

Interferon Treatment For Multiple Myeloma

1982 • 53 citations

Sequential hemi-body radiotherapy in advanced multiple myeloma

1979 • 52 citations

Intermittent high-dose prednisone (NSC-10023) therapy for multiple myeloma.

1967 • 51 citations

Clinical Results of Leukocyte Interferon-Induced Tumor Regression in Resistant Human Metastatic Cancer Resistant to Chemotherapy and/or Radiotherapy-Pulse Therapy Schedule

1985 • 47 citations

Bone marrow transplantation in multiple myeloma

1986 • 47 citations

Total body irradiation for myelomatosis.

1971 • 43 citations

Vincristine, BCNU, doxorubicin, and prednisone (VBAP) combination in the treatment of relapsing or resistant multiple myeloma: a Southwest Oncology Group study.

1982 • 41 citations

Combination chemotherapy with intermittent 1-3-bis(2-chloroethyl)1- nitrosourea (BCNU), cyclophosphamide, and prednisone for multiple myeloma

1979 • 39 citations

Adriamycin (NSC-123127) in the treatment of alkylator-resistant multiple myeloma: a pilot study.

1975 • 37 citations

Single agent vincristine by infusion in refractory multiple myeloma.

1985 • 34 citations

Nitrosoureas in multiple myeloma.

1976 • 33 citations

Treatment of refractory multiple myeloma and considerations for future therapy.

1986 • 32 citations

Treatment of multiple myeloma with M-2 protocol and without maintenance therapy

1983 • 31 citations

Diagnosis and management of multiple myeloma and related disorders.

1986 • 31 citations

Chemoimmunotherapy for multiple myeloma

1981 • 30 citations

Systemic irradiation in multiple myeloma: a report on nineteen cases

1984 • 28 citations

Timed sequential chemotherapy of cytoxan-refractory multiple myeloma with cytoxan and adriamycin based on induced tumor proliferation

1981 • 28 citations

Multiple myeloma resistant to melphalan: treatment with doxorubicin, cyclophosphamide, carmustine (BCNU), and prednisone.

1982 • 26 citations

Treatment of plasma cell neoplasm with recombinant leukocyte A interferon and human lymphoblastoid interferon

1985 • 26 citations

Hemibody irradiation in multiple myeloma

1985 • 26 citations

Phase II study of rDNA human alpha-2 interferon in multiple myeloma.

1985 • 25 citations

Adriamycin, 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC 409962), cyclophosphamide plus prednisone (ABC-P) in melphalan-resistant multiple myeloma

1978 • 25 citations

Vindesine therapy in melphalan-resistant multiple myeloma

1981 • 25 citations

Clinical and immunological studies of human fibroblast interferon

1982 • 24 citations

In Vitro Cloning and Chemosensitivity of Human Myeloma Stem Cells

1982 • 20 citations

Poly(I,C)-LC as an interferon inducer in refractory multiple myeloma.

1985 • 20 citations

Multiple myeloma resistant to melphalan: treatment with cyclophosphamide, prednisone, and BCNU.

1979 • 20 citations

Phase I-II evaluation of acronine in patients with multiple myeloma.

1983 • 19 citations

The efficacy and toxicity of VAD in the treatment of myeloma and related disorders

1986 • 18 citations

High-dose cytosine arabinoside in multiple myeloma

1984 • 17 citations

Bone Marrow Transplantation in Multiple Myeloma

1985 • 17 citations

Cross-resistance to alkylating agents in multiple myeloma

1983 • 17 citations

Phase II trials of mitomycin C, AB-100, NSC-1026, L-sarcolysin, and meta-sarcolysin, in the treatment of multiple myeloma.

1962 • 16 citations

Interferon therapy in multiple myeloma: Failure of human fibroblast interferon administration to affect the course of light chain disease

1981 • 16 citations

Treatment of lymphoid neoplasias with interferon. I. Human fibroblastic beta-interferon in malignant gammapathies. Phase II trial.

1982 • 16 citations

Peptichemio induction therapy in myelomatosis

1982 • 16 citations

Phase II trial of mitoxantrone in multiple myeloma: a Southwest Oncology Group Study.

1985 • 15 citations

Phase II study of adriamycin and bleomycin in patients with multiple myeloma.

1978 • 15 citations

Plasma cell neoplasms

1978 • 15 citations

Treatment of multiple myeloma with recombinant human leukocyte A interferon.

1985 • 15 citations

Phase I-II study of epirubicin in multiple myeloma.

1988 • 14 citations

Treatment of Multiple Myeloma

1980 • 14 citations

Procarbazine (NSC-77213) and multiple myeloma.

1970 • 14 citations

Whole bone marrow irradiation for the treatment of multiple myeloma

1982 • 14 citations

Double hemibody irradiation in chemotherapy-resistant multiple myeloma.

1984 • 13 citations

Treatment of multiple myeloma with deoxycoformycin

1985 • 12 citations

Peptichemio in pretreated patients with plasmacell neoplasms

1986 • 12 citations

Phase II evaluation of amsacrine (m-AMSA) in solid tumors, myeloma, and lymphoma: a University of Arizona and Southwest Oncology Group Study.

1983 • 11 citations

Weekly cyclophosphamide and alternate-day prednisone: an effective secondary therapy in multiple myeloma.

1987 • 10 citations

Hexamethylmelamine and prednisone in the treatment of refractory multiple myeloma.

1982 • 10 citations

Addition of cisplatin and bleomycin to vincristine-carmustine-doxorubicin-prednisone (VBAP) combination in the treatment of relapsing or resistant multiple myeloma: a Southwest Oncology Group study.

1984 • 9 citations

Phase II evaluation of etoposide in refractory multiple myeloma: a Southeastern Cancer Study Group Trial.

1986 • 9 citations

Cisplatin, BCNU, cyclophosphamide, and prednisone in multiple myeloma.

1982 • 8 citations

Phase II trial of pyrazofurin in patients with multiple myeloma refractory to standard cytotoxic therapy.

1979 • 8 citations

Phase II study of teniposide (VM-26) in multiple myeloma

1985 • 8 citations

Experimental Approaches to Drug Testing and Clonogenic Growth: Results in Multiple Myeloma and Acute Myelogenous Leukemia

1984 • 7 citations

Melphalan-resistant multiple myeloma: results of treatment according to the M-2 protocol

1985 • 6 citations

Drug - resistant multiple myeloma. A trial with the M 2 cyclic alkylating agent polychemotherapy.

1978 • 6 citations

Salvage treatment for patient with multiple myeloma refractory to alkylating agents

1985 • 6 citations

Phase II trial of piperazinedione in Hodgkin's disease, non-Hodgkin's lymphoma, and multiple myeloma: a Southwest Oncology Group study.

1977 • 5 citations

Weekly mitoxantrone therapy for refractory multiple myeloma: a Southeastern Cancer Study Group Trial.

1986 • 5 citations

Phase II study of oral methyl-CCNU and prednisone in previously treated alkylating agent-resistant multiple myeloma.

1977 • 4 citations

Treatment of Advanced Bone Marrow Neoplasms with Ifosfamide Combinations

1984 • 3 citations

Clinical trials of myeloma treatment: a review.

1986 • 2 citations

Phase II evaluation of chlorozotocin in refractory multiple myeloma.

1984 • 2 citations

Vindesine in Plasma Cell Tumors

1985 • 2 citations

Chlorozotocin: phase II evaluation in patients with myeloma.

1984 • 2 citations

Diaziquone for resistant multiple myeloma. Cancer and Leukemia Group B.

1985 • 2 citations

Prednimustine in elderly patients with multiple myeloma: a phase II study.

1986 • 2 citations

Deleted Work

1955 • 0 citations